Silencing the epidermal growth factor receptor gene with RNAi may be developed as a potential therapy for non small cell lung cancer

Lung cancer has emerged as a leading cause of cancer death in the world. Non-small cell lung cancer (NSCLC) accounts for 75–80% of all lung cancers. Current therapies are ineffective, thus new approaches are needed to improve the therapeutic ratio. Double stranded RNA (dsRNA) -mediated RNA interfere...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Min, Zhang, Xin, Bai, Chun-Xue, Song, Xian-Rang, Chen, Jie, Gao, Lei, Hu, Jie, Hong, Qun-Ying, West, Malcolm J, Wei, Ming Q
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1187910/
https://www.ncbi.nlm.nih.gov/pubmed/15987532
http://dx.doi.org/10.1186/1479-0556-3-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1187910/
https://www.ncbi.nlm.nih.gov/pubmed/15987532
http://dx.doi.org/10.1186/1479-0556-3-5

Ejemplares similares